These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4397543)

  • 1. The action of MJ1999 on the lethal effects of lanatoside C and ouabain in intact dogs.
    Sadeghi D
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):484-8. PubMed ID: 4397543
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Absence of antiarrhythmic activity of 2 adrenergic beta-blockers detected by an association of pharmacological methods].
    Vargaftig BB; Coignet JL
    Therapie; 1969; 24(5):853-8. PubMed ID: 4391431
    [No Abstract]   [Full Text] [Related]  

  • 4. Sympathomimetic action of an adrenergic beta receptor blocking agent, 4-(2-isopropylamino-1-hydroxyethyl) methanesulphonanilid hydrochloride (MJ1999).
    Agarwal SL; Bose D; Natu MV; Gandhi IS
    Indian J Med Res; 1968 Feb; 56(2):227-33. PubMed ID: 5657521
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in cardiac toxicity of ouabain in dogs after repetitive treatment with diazepam.
    Brissette Y; Gascon AL
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):127-35. PubMed ID: 27880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of Practolol (ICI 50172) on some experimental arrhythmias].
    Novelli GP; Ristori M; Ariano M
    Acta Anaesthesiol; 1969; 20(6):1111-21. PubMed ID: 4397730
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs.
    Mest HJ; Balewska I
    Biomed Biochim Acta; 1991; 50(7):943-7. PubMed ID: 1722094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 18. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 19. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. I. Bunolol and related analogs.
    Schwender CF; Farber S; Blaum C; Shavel J
    J Med Chem; 1970 Jul; 13(4):684-8. PubMed ID: 4393796
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a new beta-adrenergic receptor blocking agent, alprenolol, andts optical isomers.
    Belliveau RE; Covino BG
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):341-9. PubMed ID: 4390664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.